Early Re-intervention in Infants and Small Children After Correction of Tetralogy of Fallot

NCT ID: NCT00536432

Last Updated: 2012-06-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

93 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-09-30

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Tetralogy of Fallot is one of the most frequent congenital heart malformations. In many cases re-interventions, surgical or catheter-based, are necessary after the repair of tetralogy of Fallot in infancy. At present, informations in the literature about the myocardial benefit and the timing of re-interventions are missing in this age group. On the other hand, Fallot patients are dependent on solid criteria for re-interventions, because further interventions like replacement of the pulmonary valve or balloon dilatations of peripheral pulmonary stenoses are common.

The objective of this study is to assess the benefit of such interventions for the right ventricular function. By performing extensive standardised examinations (including MRI, echocardiography, tissue Doppler,,3D-echocardiography, holter monitoring and quality of life assessments) before and 6 to 9 months after the re-intervention data of the right ventricular function are collected. Based on these quantitative data predictive parameters concerning the right ventricular recovery and information about the time of re-intervention should be determined.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the repair of tetralogy of Fallot, pulmonary insufficiency used to be tacitly accepted as a result of extensive transannular patching (TAP) and considered unobjectionable. In fact, this is well tolerated during the first postoperative years, but today there is increasing evidence that the resulting chronic volume stress to the right ventricle is harmful on the long run, in particular if there are stenoses of the pulmonary artery in addition. Such stenoses, partly due to distortions after shunt surgery, together with pulmonary insufficiency, lead to a combined volume and pressure load of the right ventricle. The chronic volume stress results in a decrease in biventricular function and exercise tolerance, associated with increasing electrical instability with frequent, mostly ventricular, dysrhythmias. This constellation brings about a significantly increased risk of cardiac death.

Pulmonary valve replacement can improve haemodynamics, exercise tolerance and dysrhythmia. However, it is still unclear, which criteria best indicate the need for re-intervention, such as balloon dilatations of peripheral pulmonary stenoses, and what may be the best point in time in infancy.

The objective of this study is to assess the effectiveness of such interventions to the right ventricular function in small children. The data obtained are supposed to determine predictive parameters of the right ventricular recovery and to help to establish criteria for the necessity and time of re-intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tetralogy of Fallot

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Written informed consent of the patient's legal representatives
* Patients with tetralogy of Fallot (including pulmonary atresia with vsd) after corrective operation
* Patients \< 8 years with corrective surgery and necessary re-intervention (e.g.cardiac catheter intervention or re-operation )

Exclusion Criteria

* DORV (if there is another VSD than subaortic)
* Associated severe heart defects (e. g. AV canal)
* Other clinically relevant diseases, such as malignant tumor (in the investigating physician's assessment)
* MRI contraindication, e.g. cardiac pacemaker, implanted neurostimulators and other magnetizable foreign bodies
Maximum Eligible Age

7 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

German Federal Ministry of Education and Research

OTHER_GOV

Sponsor Role collaborator

Competence Network for Congenital Heart Defects

OTHER_GOV

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Samir Sarikouch, MD

Role: PRINCIPAL_INVESTIGATOR

Medizinische Hochschule Hannover, Lower Saxony

Philipp Beerbaum, MD

Role: STUDY_CHAIR

Evelina Children's Hospital, Guy's and St. Thomas Foundation Trust, Interdisciplinary Medical Imaging Group, King's College London

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universitätsklinikum Freiburg, Klinik III Päd. Kardiologie

Freiburg im Breisgau, Baden-Wurttemberg, Germany

Site Status

Universitätsklinikum Tuebingen, Klinik für Kinderheilkunde und Jugendmedizin

Tübingen, Baden-Wurttemberg, Germany

Site Status

Deutsches Herzzentrum Muenchen

Munich, Bavaria, Germany

Site Status

Medizinische Hochschule Hannover, Pädiatrische Kardiologie und Intensivmedizin

Hanover, Lower Saxony, Germany

Site Status

Herz- und Diabeteszentrum Nordrhein-Westfalen

Bad Oeynhausen, North Rhine-Westphalia, Germany

Site Status

Herzzentrum Duisburg, Kinderkardiologie

Duisburg, North Rhine-Westphalia, Germany

Site Status

Universitätsklinikum Essen, Klinik für Kinderkardiologie

Essen, North Rhine-Westphalia, Germany

Site Status

Universitätsklinikum Muenster, Klinik für Kinderkardiologie

Münster, North Rhine-Westphalia, Germany

Site Status

Deutsches Kinderherzzentrum St. Augustin

Sankt Augustin, North Rhine-Westphalia, Germany

Site Status

Universitätsklinikum des Saarlandes, Klinik für Pädiatrische Kardiologie

Homburg/Saar, Saarland, Germany

Site Status

Herzzentrum Leipzig, Klinik für Kinderkardiologie

Leipzig, Saxony, Germany

Site Status

Universitätsklinikum Schleswig-Holstein Campus Kiel, Klinik für Kinderkardiologie

Kiel, Schleswig-Holstein, Germany

Site Status

Deutsches Herzzentrum Berlin

Berlin, State of Berlin, Germany

Site Status

Universitätsklinikum Charite, Campus Virchow-Klinikum, Otto-Heubner-Centrum für Kinder- und Jugendmedizin

Berlin, State of Berlin, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Related Links

Access external resources that provide additional context or updates about the study.

http://www.kompetenznetz-ahf.de

click here for more information about the Competence Network for Congenital Heart Defects

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MP 4.2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Role of CT in Tetralogy of Fallot Diagnosis
NCT07247435 NOT_YET_RECRUITING
Resuscitation Registry in CHD
NCT05373498 RECRUITING
Femoral Arterial Cannulation
NCT00486096 TERMINATED